Evidence map›Paper›PMID 21888435›Full record

ArticleJournal of proteome research2011

Myosin binding protein-C slow is a novel substrate for protein kinase A (PKA) and C (PKC) in skeletal muscle.

Maegen A Ackermann, Aikaterini Kontrogianni-Konstantopoulos

Abstract read
In one paragraph

Article in Journal of proteome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Mechanism of post-tetanic depression of slow muscle fibres.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Molecular regulation of stretch activation.American journal of physiology. Cell physiology · 2022
    Article
  12. Article
  13. Skeletal MyBP-C isoforms tune the molecular contractility of divergent skeletal muscle systems.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Role of intrinsic disorder in muscle sarcomeres.Progress in molecular biology and translational science · 2019
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maegen A AckermannUniversity of Maryland , School of Medicine, Department of Biochemistry and Molecular Biology, 108 North Greene Street, Baltimore, Maryland 21201, United States.
Aikaterini Kontrogianni-Konstantopoulos
University of Maryland, Baltimore · US

Funding

M-Line Proteins and A-Band Assembly in Skeletal MuscleR01AR052768 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI KONTROGIANNI-KONSTANTOPOULOS, AIKATERINI · 2006 to 2010
$1.4M
MyBP-C slow variant 1: a slow isoform in a fast muscleF32AR058079 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI BORZOK, MAEGEN A. · 2010 to 2012
$159k
NIAMS NIH HHS F32 AR058079NIAMS NIH HHS R01 AR052768NIAMS NIH HHS R01 AR52768
6 · The paper itself

Abstract

Myosin Binding Protein-C slow (MyBP-C slow), a family of thick filament-associated proteins, consists of four alternatively spliced forms, namely variants 1-4. Variants 1-4 share common structures and sequences; however, they differ in three regions: variants 1 and 2 contain a novel 25-residue long insertion at the extreme NH(2)-terminus, variant 3 carries an 18-amino acid long segment within immunoglobulin (Ig) domain C7, and variant 1 contains a unique COOH-terminus consisting of 26-amino acids, while variant 4 does not possess any of these insertions. Variants 1-4 are expressed in variable amounts among skeletal muscles, exhibiting different topographies and potentially distinct functions. To date, the regulatory mechanisms that modulate the activities of MyBP-C slow are unknown. Using an array of proteomic approaches, we show that MyBP-C slow comprises a family of phosphoproteins. Ser-59 and Ser-62 are substrates for PKA, while Ser-83 and Thr-84 are substrates for PKC. Moreover, Ser-204 is a substrate for both PKA and PKC. Importantly, the levels of phosphorylated skeletal MyBP-C proteins (i.e., slow and fast) are notably increased in mouse dystrophic muscles, even though their overall amounts are significantly decreased. In brief, our studies are the first to show that the MyBP-C slow subfamily undergoes phosphorylation, which may regulate its activities in normalcy and disease.

Indexed as

AnimalsCarrier ProteinsCyclic AMP-Dependent Protein KinasesHumansMiceMice, Inbred C57BLMice, Inbred mdxMuscle, SkeletalMyosin Binding Protein CPhosphopeptidesPhosphorylationProtein IsoformsProtein Kinase CProtein Structure, TertiarySerineThreonineCarrier ProteinsCyclic AMP-Dependent Protein KinasesMyosin Binding Protein CPhosphopeptidesProtein IsoformsProtein Kinase CSerineThreonine

Identifiers

PMID21888435
PMCPMC3209537
OpenAlexW2003384078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.